Stone Ridge Asset Management LLC Bristol Myers Squibb CO Transaction History

Stone Ridge Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $3.04 Million - $4.42 Million	-65,585 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $994,042 - $1.3 Million	20,200 Added 44.51%	65,585 $4.21 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $3.83 Million - $4.54 Million	-89,500 Reduced 66.35%	45,385 $2.3 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $620,218 - $685,826	13,900 Added 11.49%	134,885 $6.12 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $866,304 - $1.03 Million	19,200 Added 18.86%	120,985 $5.77 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $964,424 - $1.25 Million	19,779 Added 24.12%	101,785 $5.29 Million
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $325,069 - $366,652	5,890 Added 7.74%	82,006 $5.09 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $470,535 - $586,469	9,312 Added 13.94%	76,116 $4.21 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $4 Million - $4.37 Million	66,804	66,804 $4.09 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.